FluoretiQ Limited (FQ)
- Home
- Companies
- FluoretiQ Limited (FQ)
- Products
- NANOPLEX - Rapid Bacterial Detection ...
NANOPLEX - Rapid Bacterial Detection Technology
NANOPLEX® enables point-of-care ID and enumeration to rapidly diagnose bacterial infections. Delivering the same quality of information expected from laboratory tests at the point of care. NANOPLEX® enables an entire product line of diagnostic devices commencing with Urinary Tract Infections: addressing over treatment and over-use of antibiotics in hospitals and community settings.
Most popular related searches

- Epithelial cells are coated in glycans, simple sugars exploited by pathogens during bacterial infection
- We have mimicked this process by engineering a proprietary library of probes capable of recognising target proteins on the surface of the bacteria.
- Probes are added directly to the sample and rapidly form glycan-binding complexes with target bacteria.
- NANOPLEX® rapidly confirms ID and CFU/ml within 15 minutes.
1. Mix
Probes are added directly to the clinical sample
2. Bind
Probes selectively bind to bacterial targets
3. Report
Probes report ID and CFU/ml within 15 minutes
